✦ LIBER ✦

Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis

✍ Scribed by Nanda, Kavinderjit S; Cheifetz, Adam S; Moss, Alan C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tu1173 Infliximab Trough Levels (IFX-Tl)

✍ Daperno, Marco; Lavagna, Alessandro; Fracchia, Mario; Guiotto, Cristina; Germano 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

P569 Clinical correlations of infliximab

✍ Daperno, M.; Lavagna, A.; Fracchia, M.; Guiotto, C.; Germano, L.; Rigazio, C.; E 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 55 KB

Trough levels and antibodies to inflixim

✍ Benjamin Pariente; Guillaume Pineton de Chambrun; Roman Krzysiek; Marine Desroch 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Tu1202 Correlation Between Infliximab Le

✍ Rivera Rivera, Edgardo D.; Liao, Chuanhong; Van't Hof, Kathleen; Mangatu, Thomas 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 806 KB

962 Clinical Utility of Measuring Inflix

✍ Waqqas Afif; Edward V. Loftus; William A. Faubion; Karen A. Hanson; William J. S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Clinical implications of variations in a

✍ Casper Steenholdt; Magid Al-khalaf; Jørn Brynskov; Klaus Bendtzen; Ole Ø. Thomse 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB